UK | pharmaphorum

UK

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

UK advisors back Moderna's bivalent shot for autumn COVID bo...

The UK's Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna's bivalent COVID-19 vaccine should be used for the autumn booster campaign in adults.

News

UK first to approve Moderna's Omicron booster jab

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

News

Dismay as UK 'drags its heels' on AZ's COVID antibody Evushe...

Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has s

News

COVID antibody declines prompts call for booster jabs ASAP

Figures from the UK Office for National Statistics (ONS) have revealed that the number of people with higher levels of COVID-19 antibodies in their blood is declining quickly – leading to c

News

Novartis' Pluvicto gets first European approval in GB

Novartis has secured its first approval in Europe for prostate cancer radioligand therapy Pluvicto, getting a green light from the UK Medicines and Healthcare products Regulatory Agency (MH

News

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricin...

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

UK advisors back Moderna's bivalent shot for autumn COVID bo...

UK first to approve Moderna's Omicron booster jab

Dismay as UK 'drags its heels' on AZ's COVID antibody Evushe...

COVID antibody declines prompts call for booster jabs ASAP

Novartis' Pluvicto gets first European approval in GB

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricin...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

UK

Editor's Picks